• The Pharma Fast 50

    PharmaTimes presents Alantra’s annual look at the fastest-growing pharma companies

  • Thumbnail

    March issue out now!

    Featuring: The UK's 50 fastest-growing pharma companies; securing the supply chain; trends in M&A and R&D; changing rare disease HTA

  • Securing the supply chain

    Counterfeit drugs are a billion-dollar industry. Could blockchain – the technology behind bitcoin – be the answer?

  • Beyond 'beyond the pill'

    How pharma companies can take patient-centricity and social responsibility a step further

  • Finding pharma's future

    With pharma changing rapidly and Brexit on the horizon, where is recruitment heading?

News

View all
Thumbnail image for Priority review for Shire’s HAE drug

Priority review for Shire’s HAE drug

US regulators are undertaking a speedy review of Shire’s lanadelumab (SHP643) for the prevention of angioedema attacks in patients 12 years and older with hereditary angioedema (HAE).

23rd February 2018

Thumbnail image for Finalists soon to be revealed!

Finalists soon to be revealed!

Clinical researchers the world over have submitted essays for this year's competition and yesterday, the authors and finalists were identified at a special meeting of the executive steering group

23rd February 2018

Web Exclusives

View all
Thumbnail image for The Pharma Fast 50

The Pharma Fast 50

PharmaTimes presents Alantra’s annual look at the fastest-growing pharma companies

Thumbnail image for Going local

Going local

Local population needs underpin the new NHS care models - so how can pharma help develop a tailored approach?

Thumbnail image for SmartPeople: Stuart Hill

SmartPeople: Stuart Hill

The business unit director, oncology, Merck UK & Ireland talks about the future of his company and the UK industry

Thought Leadership

View all
Thumbnail image for Making digital engagement truly patient-centric

Making digital engagement truly patient-centric

Digitally-augmented multi-channel engagement has proved to be a useful approach for working with patients. However, it is easy for  developers to default to a patient-facing website or an app that looks good and sounds impressive, but in practice doesn’t supply what patients want and need

Thumbnail image for PharmaMar, an innovative oncology company

PharmaMar, an innovative oncology company

PharmaMar is one of the few biopharmaceutical companies to have a product on the market, another awaiting commercialisation and various more at different stages of clinical development

Webinars

View all

Designing Pharma organisations for success

Across all industries, people are changing the ways they engage with products, services, and brands. View more...

Wednesday, 28 September 2016 - 11:00 am
George Underwood
FREE - Listen again now - | VIEW NOW

Latest jobs

View all

Senior KAM

£55000 - £70000 per annum Car, Pension and a fantastic OTE

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download